@article{feray:hal-04044132,
TITLE = {TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial},
AUTHOR = {F{\'e}ray, Cyrille and Campion, Loic and Mathurin, Philippe and Archambreaud, Isabelle and Mirabel, Xavier and Bronowicki, Jean Pierre and Rio, Emmanuel and Perret, Christophe and Mineur, Laurent and Oberti, Fr{\'e}d{\'e}ric and Touchefeu, Yann and Gournay, J{\'e}r{\^o}me and Regnault, H{\'e}l{\`e}ne and Edeline, Julien and Rode, Agn{\`e}s and Hillion, Patrick and Blanc, Jean Fr{\'e}d{\'e}ric and Khac, Eric Nguyen and Azoulay, Daniel and Luciani, Alain and Preglisasco, Athena Galetto and Faurel-Paul, Elodie and Auble, H{\'e}l{\`e}ne and Mornex, Fran{\c c}oise and Merle, Philippe},
URL = {https://u-picardie.hal.science/hal-04044132},
JOURNAL = {JHEP Reports Innovation in Hepatology},
PUBLISHER = {Elsevier},
VOLUME = {5},
NUMBER = {4},
PAGES = {100689},
YEAR = {2023},
MONTH = Apr, DOI = {10.1016/j.jhepr.2023.100689},
KEYWORDS = {3-DCRT ; three-dimensional conformal radiotherapy ; AE ; adverse event ; ALBI ; albumin--bilirubin ; BCLC ; Barcelona Clinic Liver Cancer ; CRT ; conformal radiotherapy ; CT ; computed tomography ; CTV ; clinical tumour volume ; Conformal external radiotherapy ; ECOG ; Eastern Cooperative Oncology Group ; HCC ; hepatocellular carcinoma ; HR ; hazard ratio ; Hepatocellular carcinoma ; ITT ; intention-to-treat ; OS ; overall survival ; PFS ; progression-free survival ; PS ; propensity score ; RILD ; radio-induced liver disease ; SBRT ; stereotaxic body radiation therapy ; TACE ; transcatheter arterial chemoembolisation ; TTP ; time to tumour progression ; mRECIST ; modified Response Evaluation Criteria in Solid Tumour},
PDF = {https://u-picardie.hal.science/hal-04044132/file/hal-04044132.pdf},
HAL_ID = {hal-04044132},
HAL_VERSION = {v1},
}